Overview

Evaluation of the Acceptability and Efficacy of 10 Micrograms of Estradiol Vaginal Tablets vs Promestriene Vaginal Cream

Status:
Completed
Trial end date:
2020-11-30
Target enrollment:
Participant gender:
Summary
Evaluation of the Acceptability and Efficacy of 10 Micrograms of Estradiol Vaginal Tablets vs Promestriene Vaginal Cream in postmenopausal women aged 45 years or older, with one or more moderate to severe symptoms of vulvovaginal atrophy (dryness, dyspareunia, soreness or irritation).
Phase:
Phase 3
Details
Lead Sponsor:
Instituto Palacios
Collaborator:
Novo Nordisk A/S
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Polyestradiol phosphate